SOX30 is a prognostic biomarker and chemotherapeutic indicator for advanced-stage ovarian cancer

Fei Han,Wen-bin Liu,Jian-jun Li,Ming-qian Zhang,Juntang Yang,Xi Zhang,Xianglin Hao,Li Yin,Chengyi Mao,Xiao Jiang,Jia Cao,Jinyi Liu

SOX30 is a prognostic biomarker and chemotherapeutic indicator for advanced-stage ovarian cancer

2019

Fei Han
Wen-bin Liu
Jian-jun Li
Ming-qian Zhang
Juntang Yang
Xi Zhang
Xianglin Hao
Li Yin
Chengyi Mao
Xiao Jiang
Jia Cao
Jinyi Liu

The authors and journal apologize for errors in the above paper, which appeared in volume 26 part 3, pages 303-319. The errors relate to the legend of Fig. 1A on page 307 and the artwork of Fig. 8D on page 316:

Keywords:

Cancer research
Ovarian cancer
Biomarker (medicine)
Biology
Topotecan
Metastasis
Chromosomal region
In vivo
Gemcitabine
Chemotherapy
Vimentin

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations